MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
Recruiting · NCT07036380 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma | Advanced Biliary Tract Carcinoma | Recruiting | Phase 2 | 2026-06-01 | NCT07036380 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Besancon | 73 |
| Molecular Partners AG | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Eugène Marquis | Rennes | France | 37 |
| Centre Georges-François Leclerc | Dijon | France | 7 |
| Centre Léon Bérard | Lyon | France | 71 |
| CHU de Besançon | Besançon | France | 26 |
| Chu de Grenoble | Grenoble | France | 28 |
| CHU de Montpellier | Montpellier | France | 48 |
| CHU de Tours | Tours | France | 16 |
| Hôpital Beaujon | Paris | France | 5 |
| Hôpital La Pitié-Salpétrière | Paris | France | 2 |
| Institut Curie | Paris | France | 44 |
| Institut Gustave Roussy | Villejuif | France | 58 |